La relegitimación del consumo de cannabis: perspectivas persistentes y emergentes desde el punto de vista de la bioética de la intervención
Resumen
Este artículo analiza la re-legitimación del cannabis a la luz de la Bioética de Intervención (BI), examinando la trayectoria histórica de la planta en su interacción con la humanidad, así como los impactos de la criminalización global, la cual, mediante un proceso de jerarquización étnico-racial, continúa subordinando diversas formas de vida y de saberes. Desde una perspectiva descriptiva de los problemas emergentes, el enfoque bioético se orienta hacia los impactos de descubrimientos recientes, como el papel del sistema endocannabinoide en diversos procesos fisiológicos, en particular el actual proceso de re-legitimación de ciertos usos del cannabis. En cuanto a los problemas persistentes, la BI ayuda a comprender a los conflictos históricos relacionados con la deslegitimación de los usos del cannabis en el siglo XX, especialmente en lo que respecta a sus efectos sobre la vulnerabilidad y la estigmatización. Desde una perspectiva prescriptiva, el estudio subraya la necesidad urgente de superar el prohibicionismo contra el cannabis, proponiendo valores que promuevan, sobre una base de justicia social e igualdad de oportunidades, elecciones conscientes que permitan a los sujetos fomentar una nueva relación con la psicoactividad, con las propiedades terapéuticas del cannabis y con su potencial para la libertad individual y el bienestar colectivo.
Descargas
Referencias bibliográficas
Clarke RC, Merlin MD. Cannabis: Evolution and ethnobotany. University of California Press [Internet]. 2013;147(1):149-149. Disponivel em: https://www.researchgate.net/publication/272687214_RC_Clarke_MD_Merlin_2013_-_Cannabis_Evolution_and_Ethnobotany doi: https://doi.org/10.5091/plecevo.2014.933
Balant M, Gras A, Galvez F, Garnatje T, Valles J, Vitales D. CANNUSE, a database of traditional Cannabis uses—an opportunity for new research. Database [Internet]. 2021 Jan 1. Disponivel em: https://academic.oup.com/database/article/doi/10.1093/database/baab024/6261425
DeAngelo S. The cannabis manifesto: A new paradigm for wellness. Berkeley, California: North Atlantic Books; 2015.
Ballota D, Sousa GF. Cannabis, uma substancia sob controle permanente. Revista Toxicodependencias [Internet]. 2005;11(1),37–46. Disponivel em: https://sicad.pt/PT/RevistaToxicodependencias/Paginas/detalhe.aspx?itemId=105&lista=SICAD_Artigos&bkUrl=http://www.sicad.pt/BK/RevistaToxicodependencias/Lists
Bewley-Taylor DR. International Drug Control: Consensus Fractured. Londres: Cambridge University Press; 2012.
New Frontier Data. The global cannabis report. 2019 industry outlook [Internet]. Washington (DC): New Frontier Data; 2019. Disponivel em: https://f.hubspotusercontent10.net/hubfs/3324860/Reports/NFD-GlobalCannabisReport.pdf
Souza MR de, Henriques AT, Limberger RP. Medical cannabis regulation: an overview of models around the world with emphasis on the Brazilian scenario. Journal of Cannabis Research, 2022 Jun 16;4. DOI: https://doi.org/doi.org/10.1186/s42238-022-00142-z
National Academies of Sciences E. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. nap.nationalacademies.org. National Academies of Sciences, Engineering, and Medicine [Internet]. National Academies Press (US); 2017 Jan 12; Disponivel em: https://nap.nationalacademies.org/catalog/24625/the-health-effects-of-cannabis-and-cannabinoids-the-current-state doi: https://doi.org/10.17226/24625
Liu J, Chen H, Newmaster S, Wang S, Liu C. Global Trends in Cannabis and Cannabidiol Research in the Year 1940 to 2019. Current Pharmaceutical Biotechnology, 2021; 22(5):579– 591. Disponivel em: https://pubmed.ncbi.nlm.nih.gov/32479242/ DOI: https://doi.org/10.2174/1389201021666200601152118
Cavalcante CM, Sarsur M, Dadalto L. Implicacoes bioeticas do uso terapeutico da Cannabis sativa L. no Brasil. Revista de Direito Sanitario, 2022 Dez;19;22(2):e0012. Disponivel em: https://doi.org/10.11606/issn.2316-9044.rdisan.2022.167880
Vieira VB. O uso da cannabis para fins terapeuticos requer prescricao medica ?: analise da utilizacao da maconha para fins medicinais a luz da bioetica de intervencao e outras epistemes do Sul. [Tese de doutorado]. Brasilia: Universidade de Brasilia, 2024. DOI: http://repositorio.unb.br/handle/10482/50580
Liblik SA, Cunha TR da. Liblik CS da FK, Biscioni DN, Girardi DR. Ética en el uso de psicodélicos: la definición de las drogas ilícitas bajo la óptica de la bioética crítica. Salud Colectiva, 2024 Feb 14;20:e4630. Disponivel em: https://www.scielosp.org/pdf/scol/2024.v20/e4630/es DOI: https://doi.org/10.18294/sc.2024.4630
Garrafa V, Porto D. Intervention Bioethics: A Proposal For Peripheral Countries in A Context of Power and Injustice. Bioethics [Internet]. 2003 Oct 7;(5-6):399–416. DOI: https://doi.org/doi.org/10.1111/1467-8519.00356
Figueiredo AM. Bioetica: critica ao principialismo, Constituicao brasileira e principio da dignidade humana. Rev Bioet, 2018 Oct;26(4):494–505. DOI: https://doi.org/10.1590/1983-80422018264267
Garrafa V. Da bioetica de principios a uma bioetica interventiva. Revista Bioetica [Internet]. 2005;13(1):125–34. Disponivel em: https://www.redalyc.org/articulo.oa?id=361533241011
UNESCO. Declaracao Universal sobre Bioetica e Direitos Humanos [Internet]. Paris: Unesco. 2005. Disponivel em: https://unesdoc.unesco.org/ark:/48223/pf0000146180_por
Franca JMC. Historia da maconha no Brasil. Sao Paulo: Editora Jandaira, 2022.
Saad L. Fumo de Negro: a Criminalizacao da Maconha no Pos-Abolicao. Salvador: EDUFBA, 2019.
Torcato CEM. A historia das drogas e sua proibicao no Brasil: da Colonia a Republica. [Tese de doutorado]. Sao Paulo: Universidade de Sao Paulo, 2016. 371 p. Disponivel em: https://teses.usp.br/teses/disponiveis/8/8138/tde-05102016-165617/publico/2016_CarlosEduardoMartinsTorcato_VCorr.pdf doi: https://doi.org/10.11606/T.8.2016.tde-05102016-165617
Carlini EA. A historia da maconha no Brasil. Jornal Brasileiro de Psiquiatria, 2006;55(4):314– 317. DOI: https://doi.org/10.1590/S0047-20852006000400008
Calixto JB. Twenty-five years of research on medicinal plants in Latin America. Journal of Ethnopharmacology, 2005 Aug;100(1-2):131– 134. DOI: https://doi.org/10.1016/j.jep.2005.06.004
Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 2011 Jul 12;163(7):1344– 1364. Disponivel em: https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01238.x DOI: https://doi.org/10.1111/j.1476-5381.2011.01238.x
Bewley-Taylor D, Jelsma M, Blickman T. The rise and decline of cannabis prohibition. Lodres: IDPC. 2014 Mar 11. Disponivel em: https://idpc.net/publications/2014/03/the-rise-and-decline-of-cannabis-prohibition
Klein A. Drugs and the world. Oxford: Oxford University Press. 2019.
Sanches MA, Mannes M, Cunha TR da. Vulnerabilidade moral: leitura das exclusoes no contexto da bioetica. Revista Bioetica, 2018 Jan;26(1):39–46. Disponivel em: https://www.scielo.br/pdf/bioet/v26n1/1983-8042-bioet-26-01-0039.pdf DOI: https://doi.org/10.1590/1983-80422018261224
Herer, J. The emperor wears no clothes. Los Angeles: Ah Ha Publishing, 1985.
UNODC. World Drug Report 2023 [Internet]. United Nations: Office on Drugs and Crime. 2023 [citado 2025 Jan 24]. Disponivel em: https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2023.html
Ng JY, Chang N. A bibliometric analysis of the cannabis and cannabinoid research literature. Journal of Cannabis Research [Internet]. 2022 May 25; 4(1). Disponivel em: https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-022-00133-0
Mechoulam R. A Delightful Trip Along the Pathway of Cannabinoid and Endocannabinoid Chemistry and Pharmacology. Annual Review of Pharmacology and Toxicology, 2022 Jul 18;63(1). Disponivel em: https://www.annualreviews.org/content/journals/10.1146/annurev-pharmtox-051921-083709 DOI: https://doi.org/10.1146/annurev--pharmtox-051921-083709
Solomon R. Racism and Its Effect on Cannabis Research. Cannabis and Cannabinoid Research, 2020 Mar 1;5(1):2–5. Disponivel em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173675/ DOI: https://doi.org/10.1089/can.2019.0063
Musto DF. The American disease: origins of narcotic control, 1936-2010, Borrow, and Streaming [Internet]. 2020 [citado 2025 Jan 24]. Disponivel em: https://archive.org/details/americandiseaseo0000must
Lopes RM, Ribeiro S. Maconha, cerebro e saude. Sao Paulo: Vieira & Lent Martins Fontes Paulista, 2007.
NORML. Record Number of Scientific Papers Published About Cannabis in 2021. Norml.org [Internet]. 2021 [citado 2025 Jan 24]. Disponivel em: https://norml.org/blog/2021/12/01/record-number-of-scientific-papers-published-in--2021-about-cannabis/
NORML. Review: Thousands of peer-reviewed studies specific to medical cannabis have been published over past decade. Norml.org [Internet]. 2025 [citado 2025 Feb 1]. Disponivel em: https://norml.org/news/2018/10/25/review--thousands-of-peer-reviewed-studies-specific-to-medical-cannabis-have-been-published-over-past-decade/
Provoca. #Provoca | Sidarta Ribeiro [Internet]. YouTube. 2019 [citado 2025 Jan 24]. Disponivel em: https://www.youtube.com/watch?v=mw5ou0VN91Q
Ribeiro S. As flores do bem: A ciencia e a historia da libertacao da maconha. Sao Paulo: Companhia das Letras, 2021.
Mechoulam R, Gaoni Y. A Total Synthesis of dl-Δ1-Tetrahydrocannabinol, the Active Constituent of Hashish1. Journal of the American Chemical Society, 1965 Jul [citado 2025 Jan 24];87(14):3273– 3275. Disponivel em: https://pubs.acs.org/doi/abs/10.1021/ja01092a065# DOI: https://doi.org/10.1021/ja01092a065
Galal A, Slade D, Gul W, El-Alfy A, Ferreira D, Elsohly M. Naturally Occurring and Related Synthetic Cannabinoids and their Potential Therapeutic Applications. Recent Patents on CNS Drug Discovery, 2009 Jun 1; (2):112–36. DOI: https://doi.org/10.2174/157488909788453031
Alves A de O, Spaniol B, Linden R. Canabinoides sinteticos: drogas de abuso emergentes. Sao Paulo: Revista de Psiquiatria Clinica, 2012;39(4):142– 148. DOI: https://doi.org/10.1590/S0101-60832012000400005
Wiley JL, Marusich JA, Huffman JW, Balster RL, Thomas BF. Hijacking of Basic Research: The Case of Synthetic Cannabinoids. Methods report (RTI Press) [Internet]. 2011 Nov 1. Disponivel em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567606/ DOI: https://doi.org/10.3768/rtipress.2011.op.0007.1111
Carai MAM, Colombo G, Gessa GL. Rimonabant: The first therapeutically relevant cannabinoid antagonist. Life Sciences, 2005 Sep; 77(19):2339– 2350. DOI: https://doi.org/10.1016/j.lfs.2005.04.017
Yeruva RR, Mekala HM, Sidhu M, Lippmann S. Synthetic Cannabinoids—”Spice” Can Induce a Psychosis: A Brief Review. Innovations in Clinical Neuroscience [Internet]. 2019 Jan [citado 2025 Jan 26];16(1-2):31. Disponivel em: https://pmc.ncbi.nlm.nih.gov/articles/PMC6450675/
Kaya - Anuario da Cannabis Medicinal no Brasil 2024 [Internet]. Kaya Mind - Informacoes sobre o mercado da cannabis [Internet]. 2024 [citado 2025 Jan 26]. Disponivel em: https://kayamind.com/anuario-da-cannabis-medicinal-2024/
Martorell, LB. Analise critica da bioetica de intervencao: Um exercicio de fundamentacao epistemologica [Tese de doutorado]. Brasilia: Universidade de Brasilia, 2015. Disponivel em: http://repositorio.unb.br/handle/10482/18913
Dias ECF, Ambrosino MCP, Oliveira NR de, Magalhaes JL de. A Dependencia de Insumos Farmaceuticos Importados no Brasil: Um Estudo de Caso do Medicamento Antirretroviral Nevirapina no Laboratorio Farmaceutico Oficial Farmanguinhos. Revista de Gestao em Sistemas de Saude [Internet]. 2016 Dez 1;5(2):125–33. Disponivel em: https://periodicos.uninove.br/revistargss/article/view/12764/6294
Leinen ZJ, Mohan R, Premadasa LS, Acharya A, Mohan M, Byrareddy SN. Therapeutic potential of cannabis: a comprehensive review of current and future applications. Biomedicines. 2023 Sep 25; 11(10):2630. DOI: https://doi.org/10.3390/biomedicines11102630. PMID: 37893004; PMCID: PMC10604755.
Hill A. Health, wellness, and a balanced endocannabinoid system. Caring for the Ages. 2024 Jan-Feb;25(1):15. DOI: https://doi.org/10.1016/j.carage.2023.12.011
Pogge T. Just rules for innovative pharmaceuticals. Philosophies. 2022;7(4):79. DOI: https://doi.org/10.3390/philosophies7040079
Brasil. Ministerio da Justica e Seguranca Publica. Centro de Excelencia para a Reducao da Oferta de Drogas Ilicitas (CdE). 5. Informe SAR: Canabinoides sinteticos, 07 de julho de 2023 [Internet]. Brasilia: Ministerio da Justica e Seguranca Publica. 2023 [citado 2025 Jan. 30]. Disponivel em: https://www.gov.br/mj/pt-br/assuntos/sua-protecao/politicas-sobre-drogas/subsistema-de-alerta-rapido-sobre-drogas-sar/5o-informe-sar-canabinoides-sinteticos-07-07-2023.pdf
Santos BP, Birk L, Schwarz PS, Eller SE, Oliveira TF, Arbo MD. A comprehensive analysis of legislative strategies for new psychoactive substances: the Brazilian panorama. Psychoactives. 2023;2(3):242–55. DOI: https://doi.org/10.3390/psychoactives2030016
Babayeva M, Loewy ZG. Cannabis pharmacogenomics: a path to personalized medicine. Curr Issues Mol Biol. 2023;45(4):3479– 3514. DOI: https://doi.org/10.3390/cimb45040228
| Estadísticas de artículo | |
|---|---|
| Vistas de resúmenes | |
| Vistas de PDF | |
| Descargas de PDF | |
| Vistas de HTML | |
| Otras vistas | |
Derechos de autor 2026 Revista Latinoamericana de Bioética
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
